We have purified tracer for use in the somatomedin C radioimmunoassay by hydrophobic interaction chromatography. Material showing greatest immunoreactivity binds to Octyl Sepharose CL-4B (Pharmacia) in a buffer mixture consisting of 130 mL of acetonitrile and 870 mL of 0.1 mol/L NH4HCO3, pH 7.8, but is eluted by increasing the acetonitrile content to 180 mL/L. As compared with tracer purified by binding to specific antiserum in liquid phase, precipitating the complex with second antibody, and then dissociating by gel chromatography at acid pH, this tracer shows equal immunoreactivity against specific somatomedin C antiserum. Either preparation allows excellent discrimination between extracts of normal, acromegalic, and hypopituitary plasma samples; thus either is suitable for use in the somatomedin C radioimmunoassay. Tracer purification by hydrophobic interaction chromatography is rapid and inexpensive. It may be useful in preparing highly immunoreactive tracers for other peptide radioimmunoassays.
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The usual methods for diagnosing conditions of hypo-and hypersomatotropism rely on extensive dynamic testing of pituitary function (1) . Recently, radioimmunoassays for somatomedin C (2) and related somatomedins (3) (4) (5) have been shown to provide similar diagnostic information from a single plasma specimen.
However, the lack of highly purified somatomedin for use as tracer has prevented most laboratories from performing these assays. We describe here our use of hydrophobic interaction chromatography to obtain radioiodinated somatomedin tracer of high immunoreactivity, and our comparison of tracer purified in this way with that purified by binding to specific somatomedin C antiserum. 
Methods and Results

Somatomedin C Radioimmunoassay
Preparation of Somatomedin
We extracted somatomedin from Cohn Fraction IV of human plasma (donated by Commonwealth Serum Laboratories, Melbourne, Victoria 3052) according to the somatomedin C isolation method of Svoboda et al. (7), except that the adsorption to SP Sephadex C-25 (Pharmacia (South Seas), Sydney, N.S.W. 2113) was in batch rather than on a column, and the isoelectric focusing step was performed in a 110-mL sucrose gradient (0-50%). Focusing was for 66 hat 500 V, over the pH range 3-10 with use of Pharmalyte ainpholyte (Pharmacia).
Fractions focusing at pH 8. (2) . This indicates about 20% purity relative to the somatomedin C preparation of Svoboda et al. (7) , which had an activity of about 10000 arb. units/mg in the same assay system. In the insulin radioreceptor assay (8), we found 25% displacement of bound tracer insulin by 2 ng of porcine insulin per tube or 1 tg of purified somatomedin per tube. binding to antiserum at a final dilution of 20 000-fold. To increase this to the recommended 40-50% binding, we used two methods, as described in the following sections.
Radioiodination of Somatomedin
Tracer Purification by Antibody Binding ( -RIA) , the pellet, containing 15-20% of the original radioactivity, was redissolved in 0.5 mL of a mixture containing, per liter, 20 mmol of HC1, 50 mmol of NaC1, and 2.5 g of bovine albumin (pH 2.0) and chromatographed on a 0.8 X 34 cm column of Sephadex G-50 (fine) in the same buffer, to separate tracer from the antibody complex. As shown in Figure 1 , a symmetrical peak of radioactivity was obtained from this column at Kd 0.3-0.6. Tracer purified in this way typically showed 45-50% binding to antiserum at 20 000-fold dilution, and 80-85% binding to excess (4000-fold dilution) antiserum.
Tracer Purification by Hydrophobic Interaction Chromatography
Because tracer purification by antibody binding required the use of large amounts of antiserum, we devised an alternative method. A 0.7 X 5 cm bed of Octyl Sepharose CL-4B (Pharmacia) was packed in a siliconized disposable polypropylene column, and equilibrated with 12 mL of buffer containing NH4HCO3 (0.1 mol/L, pH 7.8) and acetonitrile in the ratio 87:13 by volume ("13% acetonitrile").
We applied 5-10 tCi of unpurified tracer from Sephadex G-50 chromatography in a volume of 50 zL to the column and washed it with 12 mL of column equilibration buffer, discarding the eluate. We then applied buffer containing 0.1 mol/L NH4HCO3 and acetonitrile, 82:18 by volume ("18% acetonitrile"), and collected the eluate in 1-mL fractions. The flow rate, about 0.5-1 mL/min, allowed the separation to be completed in less than 1 h. Figure 2 shows the radioactivity elution profile of a typical column. Radioactivity eluted by 13% acetonitrile had very low immunoreactivity, while the peak fraction (fraction 15) eluted with 18% acetonitrile typically showed 45-50% binding to antiserum at 20 000-fold dilution, and 76-80% to excess (4000-fold dilution) antiserum. This fraction routinely contained 15-20% of the applied radioactivity, when volumes of tracer up to 250 L were loaded. (12) . It seems likely that this method may be scaled up to provide a final purification step for somatomedin C isolation from human plasma, taking the place of the "high-pressure" liquid chromatography used by Svoboda et al. (7) . Finally, hydrophobic interaction chromatography is rapid and inexpensive, and may prove to be a useful method of providing highly immunoreactive tracer for a variety of other peptide radioimmunoassays.
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